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Abstract
HIV-1 is a RNA virus that requires an intermediate DNA phase via reverse transcription (RT) step in order to establish
productive infection in the host cell. The nascent viral DNA synthesized via RT step and the preformed viral proteins are
assembled into pre-integration complex (PIC) in the cell cytoplasm. To integrate the viral DNA into the host genome, the PIC
must cross cell nuclear membrane through the nuclear pore complex (NPC). RanBP2, also known as Nup358, is a major
component of the cytoplasmic filaments that emanates from the nuclear pore complex and has been implicated in various
nucleo-cytoplasmic transport pathways including those for HIV Rev-protein. We sought to investigate the role of RanBP2 in
HIV-1 replication. In our investigations, we found that RanBP2 depletion via RNAi resulted in profound inhibition of HIV-1
infection and played a pivotal role in the nuclear entry of HIV DNA. More precisely, there was a profound decline in 2-LTR
DNA copies (marker for nuclear entry of HIV DNA) and an unchanged level of viral reverse transcription in RanBP2-ablated
HIV-infected cells compared to RanBP3-depleted or non-specific siRNA controls. We further demonstrated that the function
of Rev was unaffected in RanBP2-depleted latently HIV infected cells (reactivated). We also serendipitously found that
RanBP2 depletion inhibited the global ectopic gene expression. In conclusion, RanBP2 is a host factor that is involved in the
nuclear import of HIV-1 PIC (DNA), but is not critical to the nuclear export of the viral mRNAs or nucleo-cytoplasmic
shuttling of Rev. RanBP2 could be a potential target for efficient inhibition of HIV.
Citation: Zhang R, Mehla R, Chauhan A (2010) Perturbation of Host Nuclear Membrane Component RanBP2 Impairs the Nuclear Import of Human
Immunodeficiency Virus -1 Preintegration Complex (DNA). PLoS ONE 5(12): e15620. doi:10.1371/journal.pone.0015620
Editor: Neeraj Vij, Johns Hopkins School of Medicine, United States of America
Received September 19, 2010; Accepted November 15, 2010; Published December 14, 2010
Copyright:  2010 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported with federal funds from National Institute of Neurological Disorders (NINDS), National Institutes of Health grant RO1 NS
050064 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Ashok.Chauhan@uscmed.sc.edu
Introduction
The nuclear pore complexes (NPCs) are channels in the nuclear
membrane that regulate trafficking across the nuclear envelope
(NE) [1]. NPCs are composed of multiple copies of approximately
30 proteins, known as nucleoporins (Nups) [2–5]. Most of the
Nups contain phenylalanine-glycine (FG) repeats, which line the
central channel and extend on both the cytoplasmic and the
nucleoplasmic faces. The FG repeat domains are responsible for
interaction with transport receptors and thus provide binding sites
for receptor-cargo complexes to allow selective entry across the
NPCs [6–9]. RanBP2, also known as Nup358, is a major
component of cytoplasmic filaments of NPC [10–12].
Several studies showed that RanBP2 regulates the shuttling of
HIV-1 Rev protein between the cytoplasm and the nucleus [13–
14]. Rev protein promotes the nuclear export of Rev responsive
element (RRE)-containing unspliced or partially spliced HIV
mRNA species [15–16]. HIV-Rev bears a nuclear localization
signal (NLS) and a leucine-rich nuclear export signal (NES) that
allow it to continuously shuttle between the cytoplasm and the
nucleus [17–18]. Upon Rev synthesis in the cytoplasm, the import
receptors bind to its NLS, leading to its transportation into the
nucleus [18]. Once in the nucleus, Rev binds with RRE of HIV-
mRNAs and the leucine-rich NES of Rev is recognized by CRM1,
a nuclear export receptor that facilitates the nuclear export of
mRNA-Rev complex [17,19,20]. It is shown that depletion of
RanBP2 by siRNA strongly inhibits the nuclear import of HIV-1
Rev protein [13]. Subsequently, another study showed that
RanBP2 depletion blocked CRM1-mediated NES protein export
and caused predominant nuclear accumulation of HIV-1 Rev
protein [14]. Since shuttling of HIV-1 Rev is required for the
nuclear export of HIV mRNAs and for the virus to complete its
life cycle, the role of RanBP2 becomes essential for HIV-1
replication.
The capacity of HIV-1 to infect both the dividing and non-
dividing cells indicates that the viral DNA assembles into HIV-1
preintegration complex (PIC) and actively crosses the nuclear
envelope by taking advantage of the cellular nuclear import
machinery. The nuclear import of HIV-1 DNA is a critical step in
viral life cycle and the mechanism for nuclear entry is still poorly
understood. Upon HIV-1 infection, the genomic viral RNA is
reverse transcribed into viral DNA. The nascent viral DNA
assembles into PIC with a three-stranded DNA, specified by the
central polypurine tract central sequence (cPPT-CTS), and several
viral proteins such as nucleocapsid (NC), matrix protein (MA),
reverse transcriptase (RT), integrase (IN) and Vpr proteins
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signals and thus can be recognized by the nuclear import receptors
that allow subsequent translocation of the whole complex into the
nucleus via cellular active transport machinery [21,29–30]. Albeit,
the role of IN, MA, Vpr and cPPT-CTS in the nuclear import of
HIV DNA has been refuted by several studies [31–39,69],
however, a recent study has shown a proven role for cPPT-CTS
in the PIC nuclear import [28]. Yet, more studies are needed to
validate specifically which viral components are required for the
PIC import.
In addition, to viral components the NPC components,
obviously, are required in the process to deliver the PIC into the
nucleus. The PIC cargo is transported across the NPC involving
the network of several Nups and import receptors [40]. It has been
shown that Nup153, a major component of nuclear filament of
NPC, directly interacts with the viral IN, a component of HIV-1
PIC, and is essential for the nuclear entry of HIV-1 DNA [41].
Also, depletion of Nup98, which is located near the nuclear basket
and dynamically associates with and dissociates from the nuclear
pore, impairs the nuclear import of HIV-1 cDNA [42]. In the two
genome wide siRNA screening studies [40,43] and a functional
study [44] show that TNPO3 or transportin 3, a member of
karyopherin beta protein family, is intimately involved in the PIC
nuclear import. This was further validated by another study
wherein the viral capsid (CA) protein instead of IN is a major viral
protein that mediates the transportation of PIC into the nucleus
[45]. Interestingly, in global siRNA screening study, Nup153,
Nup214 (a major component of distal ring) and RanBP2/Nup358
were identified to be essential nucleoporins responsible for
mediating the nuclear import of HIV-1 DNA [40]. Thus, it is
possible that RanBP2 is a part of the Nups network and plays an
essential role in translocating HIV-1 PIC from the cytoplasm into
the nucleus.
Based on the earlier evidences that RanBP2 is involved in
regulation of HIV-1 Rev nucleo-cytoplasmic trafficking and HIV
DNA import, we sought to investigate the role of RanBP2 in HIV-
1 replication using RNAi and HIV infection. We used RNAi
strategy to deplete RanBP2 and found that the nuclear entry of
HIV-1 DNA was largely impaired, leading to profound inhibition
of HIV-1 replication. We also found that RanBP2 ablation had no
effect on the viral mRNA export. Further, we serendipitously
found that RanBP2 depletion universally inhibited the ectopic
gene expression and might not be necessarily specific for the HIV.
Results
RNAi mediated knockdown of RanBP2 and RanBP3
We sought to examine the role of RanBP2 in HIV-1 life cycle,
in particular the possible role in Rev-function and PIC nuclear
import. In order to investigate the role of RanBP2, RNAi
approach was validated using specific siRNA. Western blot
analysis showed that when specific siRNA was transfected at
concentration as low as 20 nM, RanBP2 protein was robustly
knocked down after 72 hrs (Fig. 1). The scrambled siRNA and the
cells without siRNA were used as controls. As an internal control
to exclude the unexpected non-specific siRNA effects in the
functional assays we also included siRNA targeting Ran-binding
protein 3 (RanBP3), an accessory factor in Ran GTPase system
[53]. Similar to RanBP2 siRNA, RanBP3 siRNA ablated RanBP3
protein completely when used at 200 nM concentrations (Fig. 1).
RanBP2 regulates ectopic gene expression
Rev protein is an essential viral protein that regulates the
temporal HIV-1 gene expression. Earlier studies have shown that
RanBP2 regulates the nucleo-cytoplasmic trafficking of HIV-1
Rev protein [13–14]. Although impressive, these experimental
observations, however, were based on the usage of plasmid
expression vectors via transfection and were not substantiated by
HIV infection studies. To address whether the function of HIV-1
Rev protein is impaired in RanBP2 depleted cells, we have
established SVGA-LTR-gag-GFP reporter cells wherein the
expression of gag-GFP fusion product under HIV-LTR promoter
is regulated by both Tat and Rev proteins. The stable monoclonal
LTR-gag-GFP-RRE reporter cells were transfected with either the
wild type HIV provirus NL4-3, or the HIV provirus with mutant
Rev, pMRev(-) as a control, and monitored for GFP expression.
The GFP expression was observed only in cells with wild type HIV
provirus (Fig. 2A). We then used these reporter cells to test the
role of RanBP2 in Rev-mediated mRNA export. SVGA-LTR-
gag-GFP reporter cells transfected with either RanBP2 siRNA,
RanBP3 siRNA or scrambled siRNA were co-transfected 48 hrs
later with pCMV-Tat and pCMV-Rev expression vectors, and
monitored for the GFP expression. We observed a profound
decrease in GFP expression in RanBP2 siRNA transfected
reporter cells compared to RanBP3 (negative control) or
scrambled siRNA ones (Fig. 2B). The CRM1, a host nuclear
shuttling protein, is involved in Rev-mediated nuclear export of
HIV mRNAs. Leptomycin B (LMB), a known inhibitor of CRM1-
mediated mRNA export pathway [54], was used as a positive
control and revealed a robust inhibitory effect on the GFP
expression (Fig. 2B).
Since GFP expression in SVGA-LTR-gag-GFP reporter cells is
dependent on both Tat-mediated LTR activation and Rev-
mediated mRNA export, the above results indicate that RanBP2
knockdown must have blocked either Tat-mediated transactiva-
tion of LTR promoter or Rev-mediated mRNA export. To further
investigate whether RanBP2 depletion attenuates Tat-mediated
transactivation of LTR-promoter, we used SVGA-LTR-GFP
reporter cells wherein the GFP expression is dependent on Tat
protein, but independent of Rev, and observed robust Tat-
dependent GFP expression (Fig. 3A). After validating the reporter
system, we transfected reporter cells either with RanBP2 siRNA or
scrambled siRNA, followed by transfection with pCMV-Tat
expression vector 48 hr later. Intriguingly, we found that Tat-
driven GFP expression was profoundly inhibited in RanBP2-
depleted but not in scrambled siRNA transfected reporter cells
(Fig. 3B).
Inhibition of Tat-dependent LTR-GFP expression in RanBP2-
depleted cells led us to investigate the mechanism further. To
exclude the possibility that functional Tat protein do get expressed
in the cytoplasm of RanBP2-depleted cells but is inhibited at the
nuclear import level, we used Tat-GFP expression vector wherein
Tat is expressed as a fusion protein with GFP to test the
hypothesis. SVGA cells transfected with either RanBP2 siRNA,
RanBP3 siRNA or scrambled siRNA, were transfected 48 hrs later
with Tat-GFP expression vector and monitored for GFP
expression. GFP expression was dramatically decreased in
RanBP2 ablated but not in RanBP3 or scrambled siRNA
transfected cells (Fig. 3C). This observation demonstrated that
RanBP2 ablation inhibited Tat expression. We then sought to
investigate whether the inhibitory effect was Tat-specific or
universal. We used pDTat-GFP (GFP gene fused with mutant
Tat gene wherein 48-56 amino acids were deleted) and pEGFP
expression vector systems to validate the above findings.
Unambiguously, we observed pronounced GFP expression decline
in RanBP2-ablated SVGA cells compared to control siRNAs
(Fig. 3C). These observations inferred that, rather than specific
inhibition of Tat expression, RanBP2 knockdown inhibits global
RanBP2 Promotes HIV-1 DNA Import
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gag-GFP-RRE and SVGA-LTR-GFP reporter systems, we
serendipitously found that RanBP2 was universally indispensible
in ectopic gene expression.
We further sought to investigate the specific role RanBP2 plays
in the ectopic gene expression and whether it regulates stable GFP
expression and is involved in the nuclear export of the mRNAs
encoded from plasmid vectors. To test the hypothesis and rule out
the transfection based reporter expression (transient expression)
influence, SVGA-GFP transgenic cells with stable GFP is
expression, were chosen to examine whether RanBP2 knockdown
interfered with the nuclear export of GFP mRNA (absence of GFP
expression). SVGA-GFP cells were transfected either with RanBP2
siRNA, RanBP3 siRNA (negative control), scrambled siRNA or
GFP siRNA as a positive control. The siRNAs transfected cells
were cultured for 5 days and examined for GFP fluorescence every
day. Surprisingly, the GFP expression in RanBP2-depleted cells
was similar to RanBP3 or scrambled siRNA transfected cells, while
GFP siRNA dramatically inhibited GFP expression since the
second day of siRNA transfection. The images were captured and
the GFP-positive cells were quantified by flow cytometry on 3
rd
day after the siRNA transfection (Fig. 4). These results clearly
demonstrated that RanBP2 siRNA did not interfere with the
nuclear export of mRNA but might be playing a role in the
nuclear import of DNA.
RanBP2 ablation does not impair nuclear export of HIV
mRNAs or expression of HIV early gene products
RanBP2 ablation had no impact on the GFP mRNA expression
and its translation in the stable cells (Fig. 4). However, it remains
yet to be elucidated whether RanBP2 is essential in Rev-mediated
nuclear export of unspliced or partially spliced HIV mRNA
species. To corroborate whether RanBP2 regulates Rev-mediated
nuclear export of HIV-1 mRNA, we took advantage of the latently
HIV-1 infected cell system – THP89 cells. THP89 is a monocytic
cell line latently infected with recombinant p89.6 HIV-1 reporter
virus wherein the GFP gene is inserted in the viral genome [48].
These latently HIV-1 infected cells are transcriptionally silent and
show no viral mRNA transcripts and their translated products
unless reactivated by either TNF-a, histone deacetylase inhibitor
Trichostatin A (TSA, or protein kinase C (PKC) activator
bryostatin [48,51,52]. To perform reactivation studies on latent
THP89 cells, we used bryostatin, a drug that is recently shown by
us to be very potent in reactivation of latent HIV-1 [52]. Upon
bryostatin mediated reactivation, the viral mRNAs are exported
from the nucleus into the cytoplasm either for translation into
Figure 1. siRNA-mediated depletion of RanBP2 and RanBP3. SVGA cells were transfected either with RanBP2 siRNA or RanBP3 siRNA,
respectively. In parallel, control SVGA cells were either transfected with 200 nM scrambled siRNA or without siRNA. Total proteins were extracted 72 h
post siRNA transfection. Western blot analysis was performed to examine levels of RanBP2 and RanBP3, respectively. Actin was used as internal
control. Image J was used to analyze the intensities of the bands.
doi:10.1371/journal.pone.0015620.g001
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PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15620Figure 2. RanBP2 depletion impairs biological activities of ectopically expressed Tat and Rev HIV proteins. (A) Schematic diagram of
Tat/Rev responsive SVGA-LTR-gag-GFP cells is shown. The cells were transfected with either 50 ng NL4-3 plasmid, or 50 ng NL4-3 (Rev-). Fluorescent
images were captured 48 h post transfection. (B) SVGA-LTR-gag-GFP reporter cells were transfected either with RanBP2 siRNA, RanBP3 siRNA
(negative control) or scrambled siRNA (control). 48 h later, the cells were then co-transfected with 50 ng pCMV-Tat and 200 ng pCMV-Rev. In parallel,
Leptomycin B was used as positive control and was added 4 h after the transfection of reporter cells (pre-transfected with scrambled siRNA) with
pCMV-Tat and pCMV-Rev. The images were captured and GFP positive cells were analyzed by flow cytometry 48 h post plasmid transfection.
doi:10.1371/journal.pone.0015620.g002
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into viral particles.
THP89 cell line is thus an ideal system to study whether
RanBP2 is directly involved in the nuclear export of viral mRNAs
and is superior to transfection and infection experiments wherein
viral DNA nuclear import and integration are additional steps to
be suspected before concluding Rev function. Before performing
the actual experiments, we first checked the efficacy of RanBP2
siRNA in depleting the protein in THP89 cells. As expected,
RanBP2 protein was profoundly depleted by the specific siRNA
and was not detectable 72 hr post siRNA transfection and such
effect was not seen in control siRNAs (Fig. 5A). In order to study
the effect of RanBP2 on mRNA expression, we performed siRNA
inhibition studies in the presence or absence of bryostatin and
observed that bryostatin had no interference with RanBP2 siRNA
performance (Fig. 5A). Thereafter, THP89 cells were first
transfected either with RanBP2, RanBP3 siRNA or scrambled
siRNA. In parallel, GFP siRNA was used as a positive control.
48 hrs after siRNA transfection, the cells were treated with
bryostatin.
Viral reactivation in bryostatin treated THP89 cells was
monitored by GFP expression (fluorescence microscopy and flow
cytometry), and viral p24 antigen in the culture supernants by
ELISA. Fluorescence microscopy and flow cytometry analysis
Figure 3. RanBP2 depletion inhibits global ectopic gene expression. (A) Schematic diagram of Tat responsive SVGA-LTR-GFP reporter cells is
shown. Cells were either transfected with 500 ng pCMV-Tat or pcDNA vector (control) and images were captured 48 h after transfection. (B) SVGA-
LTR-GFP reporter cells were transfected either with series of concentrations of RanBP2 siRNA or scrambled siRNA. 48 h later, the cells were transfected
with 500 ng pCMV-Tat. After 48 h the images were captured and GFP positive cells were analyzed by flow cytometry. (C) SVGA cells were transfected
either with 100 nM RanBP2 siRNA, 200 nM RanBP3 siRNA or 100 nM scrambled siRNA. 48 h later, the cells were then transfected either with 100 ng
pEGFP, 100 ng pTat-GFP or 100 ng pDTat-GFP plasmids respectively. The GFP expression was examined 48 h later by capturing the images and
analysis by flow cytometry.
doi:10.1371/journal.pone.0015620.g003
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scrambled siRNA transfected cells but profound decline in
fluorescence was seen in GFP siRNA transfected cells (positive
control). Flow cytometry data was validated by p24 antigen levels
(a marker for productive HIV infection) wherein no effect of
RanBP2 depletion was seen (Fig. 5B–D). Overall, these results
unambiguously demonstrate that RanBP2 does not play a role in
the nuclear export of HIV-1 mRNA species via Rev and this is in
contrast to the earlier studies [13,14].
RanBP2 depletion inhibits HIV-1 replication
In order to investigate the role of RanBP2 in HIV-1 replication,
we performed RNAi studies on Magi cells, a Hela cell line that
expresses CD4, CCR5, and CXCR4 receptors, followed by the
viral infection. As a positive control, we used siRNA targeting
transportin 3 (TNPO3), a known host factor that is essential in
HIV-1 replication and promotes viral DNA nuclear import
[44,45,55]. Magi cells transfected either with RanBP2 siRNA,
RanBP3 siRNA (negative control), scrambled siRNA (control), or
TNPO3 siRNA (positive control), and were further transduced
with VSV-G pseudotyped NLENY1, a recombinant HIV-1
expressing YFP [51]. The rationale of using VSV-HIV particles,
as against the wild type virus, was to achieve homogenous and
rapid infection within two days in order to obtain consistent end
points in the dividing cells (different cell types). The YFP-gene in
NLENY1 is cloned between the HIV env- and -nef genes using
IRES (internal ribosome entry site sequence) and hence, will
encode partially spliced Env-GFP mRNA (translates into two
separate proteins) and expression will be dependent on functional
Rev-protein. The end point after infection was monitored by YFP
expression in the infected cells as its expression was dependent on
the functional Rev-protein. RanBP2 siRNA similar to TNPO3
siRNA robustly diminished the YFP expression as well as viral p24
antigen levels compared to the RanBP3 or scrambled siRNA
controls (Fig. 6A).
To corroborate that the inhibitory effect conferred by RanBP2
siRNA was not cell type specific, we further validated our findings
by using a different cell system – SVGA cells, the astrocytic cell
line commonly used in our LTR-reporter assays. Remarkably,
RanBP2 depletion in SVGA cells similar to Magi cells revealed a
significant decrease in the YFP-positive cells compared to RanBP3
or scrambled siRNA transfected cells (Fig. 6B). Further, we took
advantage of Rev-independent expression of the HIV early
proteins to investigate whether RanBP2-depleted cells could
Figure 4. RanBP2 depletion does not inhibit GFP expression in SVGA-GFP transgenic cells. Stable SVGA-GFP cells were transfected
overnight either with 100 nM RanBP2 siRNA, 200 nM RanBP3 siRNA (negative control), 100 nM scrambled siRNA (control), or 100 nM GFP siRNA as a
positive control. The cells were then followed up for 5 days. On day 3 images were captured and the GFP positive cells were analyzed by flow
cytometry.
doi:10.1371/journal.pone.0015620.g004
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reporter cells in combination with VSV-pseudotyped NL4-3 virus.
The hypothesis is that VSV-HIV infection in RanBP2 depleted
cells synthesizes viral mRNAs, and the transportation and
expression of Tat mRNA should be independent of Rev function
but dependent on the cellular mRNA transport machinery. Should
the Tat expression in the above be undetectable, the possible
reason would be that VSV-HIV infection in RanBP2-depleted
cells has an impeded viral DNA nuclear import and hence no
genomic viral integration, transcription and early viral proteins
synthesis. SVGA-LTR-GFP reporter cells were depleted for
RanBP2, 48 hrs later followed by transduction with VSV-HIV
and examined for Tat-driven LTR mediated GFP expression.
VSV-HIV transduced RanBP2-depleted SVGA-LTR-GFP cells
showed profound decline in GFP positive cells compared to wild
type cells or cells transfected with either RanBP3 siRNA or
scrambled siRNA (Fig. 6C). Since Tat expression is a downstream
event of nuclear entry of viral DNA, its low expression, obviously,
can be explained by the impeded nuclear import of the viral DNA
in RanBP2 depleted cells.
In order to confirm the role of RanBP2 in viral regulation, we
further validated our data using a HIV-1 derived lentiviral vector
Figure 5. RanBP2 depletion does not interfere with nuclear export of viral mRNA species. (A) Latently HIV infected monocytic (THP89)
cells were transfected with 100 nM RanBP2 siRNA and total proteins were extracted 48 or 72 h post transfection. Western blot analysis revealed the
levels of RanBP2 protein. RanBP2 level in cells that were transfected with 100 nM RanBP2 siRNA followed by bryostatin treatment were also examined
the performance on viral activity. THP89 cells either transfected with scramble siRNA or left untransfected were used controls. (B–D) THP89 cells were
first transfected either with RanBP2 siRNA, RanBP3 siRNA, scrambled siRNA or GFP siRNA as a positive control. 48 h later, the cells were reactivated
with 25 ng/ml bryostatin (potent reactivator of latent HIV infection). The GFP expression was examined 48 hrs after bryostatin treatment. (B) The
Images were captured and (C) GFP positive cells were analyzed by flow cytometry. (D) Supernatants collected in (B) were analyzed for p24 levels by
ELISA.
doi:10.1371/journal.pone.0015620.g005
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HIV proteins. We used a pLVX-GFP expressing lentiviral vector
that does not require any HIV proteins to express GFP and was
packaged with VSV-G envelope. SVGA cells transfected 48 hrs
earlier either with RanBP2 siRNA, RanBP3 siRNA, scrambled
siRNA or TNPO3 siRNA, were transduced with VSV-G
Figure 6. RanBP2 depletion inhibits HIV-1 replication and lentiviral vector gene expression. (A) Magi cells were transfected either with
RanBP2 siRNA, RanBP3 siRNA (negative control), TNPO3 siRNA (positive control) or scrambled siRNA (control). 48 h later, the cells were transduced
with 200 ng/ml p24 equivalent VSV-NLENY1 (recombinant HIV virus containing YFP) for 16 h. The fluorescent images were taken 48 h post
transduction followed by collection of the culture supernatants for p24 (ELISA). The YFP positive cells were analyzed by flow cytometry (p,0.01). (B)
SVGA cells were transfected either with RanBP2 siRNA, RanBP3 siRNA or scrambled siRNA. 48 h later, the cells were transduced with 200 ng/ml p24
equivalent VSV-NLENY1 for 16 h. The fluorescent images were captured 48 h post transduction by digital camera (Nikon) and YFP positive cells were
analyzed by flow cytometry (p,0.001). (C) SVGA-LTR-GFP reporter cells were transduced either with RanBP2 siRNA, RanBP3 siRNA (negative control),
scramble siRNA or TNPO3 siRNA as a positive control. 48 hrs later, the cells were then transduced with 200 ng/ml p24 equivalent VSV-NL4-3. Images
were captured 48 h after transduction and the GFP positive cells were analyzed by flow cytometry (p,0.01). (D) SVGA cells were transfected either
with RanBP2 siRNA, RanBP3 siRNA, TNPO3 siRNA or scrambled siRNA. 48 h later, the cells were transduced with VSV-G pseudotyped lentiviral vector.
The fluorescent images were captured 48 h after transduction and GFP positive cells were analyzed by flow cytometry (p,0.01).
doi:10.1371/journal.pone.0015620.g006
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microscopy and flow cytometry, it was observed that RanBP2
siRNA and TNPO3 siRNA, similar to the earlier experiments
using VSV-HIV (Fig. 6A, B), dramatically inhibited the lentiviral
vector mediated GFP expression compared to RanBP3 siRNA or
scrambled siRNA (Fig. 6D). These results provide evidence that
RanBP2, a host nuclear membrane component, is critical in
establishing productive HIV infection. The above findings also
revealed that RanBP2-depletion impairs HIV life cycle upstream
of the early viral protein expression but at least not at the viral
entry level as VSV-pseudotyped virus particles entry is receptor
independent.
RanBP2 depletion inhibits nuclear import of HIV-1 DNA
(PIC)
NPC plays a critical role in nuclear import of HIV DNA and in
a global siRNA screening study RanBP2 has been shown to be
involved in the viral DNA import [40]. Also, RanBP2 is involved
in cellular nucleo-cytoplasmic trafficking as shown in the earlier
studies [13,14,40]. After validation of non-involvement of RanBP2
in the viral mRNAs export we then sought to investigate whether it
promotes nuclear entry of the viral DNA. To study HIV-DNA
nuclear import in absence of RanBP2, we took advantage of 2-
LTR circles of viral DNA, a marker for the nuclear import of
HIV-1 DNA [56–58]. SVGA cells were first transfected either
with RanBP2 siRNA, RanBP3 siRNA, scrambled siRNA or
TNPO3 siRNA as a positive control. The siRNA transfected cells,
48 hrs later were transduced with VSV-G pseudotyped HIV, and
the total DNA was extracted 24 hrs later, (viral DNA enters the
nucleus around 16 hrs post infection [56]). The levels of 2-LTR
circles in the extracted DNA were measured by using real time
PCR. There was a profound decrease in the levels of 2-LTR
circles in RanBP2- and TNPO3 (positive control)-depleted cells
but not in RanBP3 (negative control)-depleted or scrambled
siRNA transfected cells (Fig. 7A).
To corroborate the above results we utilized another cell system
Magi cells and performed similar knockdown studies. Strikingly,
RanBP2-depleted Magi cells revealed reduced levels of the 2-LTR
circles similar to TNPO3-depleted cells (positive control) but not
RanBP3 or scrambled siRNA controls (Fig. 7A). To rule out any
inhibitory effect of RanBP2 siRNA on viral reverse transcription,
we further examined the levels of viral late reverse transcription
products 12 hrs after the virus infection that would reflect the total
viral DNA synthesized in RanBP2 depleted cells and the controls.
Indeed, we observed that the treatment with RanBP2 siRNA or
control siRNA does not show any inhibitory effect on the total
reverse transcribed viral DNA, whereas AZT treated cells (positive
control that inhibits the viral reverse transcriptase) revealed
absence of RT-product (Fig. 7B). The above results suggest that
RanBP2 knockdown does not interfere at the viral entry and the
reverse transcription steps.
All together, in two different systems, reduction in 2-LTR DNA
circles formation but occurrence of equal amounts of reverse
transcription products in RanBP2-depleted cells demonstrated that
RanBP2 plays a pivotal role in nuclear import of HIV DNA (PIC).
Taken together, our multiple lines of evidence confirm that
RanBP2 is a required host factor for HIV-1 replication and
promotes the nuclear entry of HIV-DNA but not the nuclear
export of viral mRNA species.
Discussion
In this study, we investigated the role of RanBP2 and found that
it is an essential host factor for HIV-1 infection and is involved in
promoting the nuclear import of HIV-1 DNA. The nuclear export
of viral mRNAs was unaffected in RanBP2 depleted cells. Further,
we showed that RanBP2 is indispensable in ectopic gene
expression via plasmid vectors and transduction of HIV/lentiviral
particles, substantiating its role in the nuclear DNA import.
To investigate the specific steps blocked by RanBP2 depletion,
sequentially, we first examined whether the function of HIV-1 Rev
protein is impaired. THP89 cells, that are latently infected with
HIV-1 and can be reactivated upon treatment with either
bryostatin or TNF-a, provided an excellent model to study the
nuclear export of HIV-1 mRNAs. Upon bryostatin treatment,
HIV-1 transcription is activated and subsequently the synthesized
viral mRNAs are exported from the nucleus into the cytoplasm to
allow the viral protein synthesis and completion of the viral life
cycle. Thus, impaired viral replication in RanBP2-depleted
THP89 cells upon treatment with bryostatin can imply a deficient
nuclear export of the viral mRNA species and absence of the
translated proteins (GFP/p24). Our data clearly show that
RanBP2 depletion does not affect HIV-1 replication in reactivated
THP-89 cells (Fig. 5), suggesting that RanBP2 does not function
in the nuclear export of viral mRNAs.
Since HIV-1 Rev shuttles between the cytoplasm and the
nucleus and is responsible for the nuclear export of unspliced and
partially spliced viral mRNAs, our data clearly demonstrate that
RanBP2 does not interfere in the nuclear-cytoplasmic shuttling of
HIV Rev protein, as no viral replication block was found in our
latent HIV–reactivation model. This is contrary to earlier reports
demonstrating that nuclear import of HIV-1 Rev is mediated
mainly by the transportin, a nuclear import receptor, and that
depletion of RanBP2 inhibits all transportin - mediated nuclear
import and causes accumulation of Rev in the cytoplasm [13].
Similarly, another study shows that depletion of RanBP2
mislocalizes CRM1, the host export receptor that mediates
HIV-1 Rev nuclear export and subsequently causes accumulation
of Rev in the nucleus [14]. In both the studies, Rev-BFP plasmid
was transiently transfected into RanBP2 depleted cells and
percentages of nuclear localized- or cytoplasmic localized-Rev
positive cells were measured. Therefore, we argue that the
inherent weaknesses in both the studies lie in the experimental
models itself and the conclusion extended may not be appropriate
in transient ectopic gene expression system. In contrast, global
impact of RanBP2 depletion in ectopic gene expression (Fig. 2, 3)
but not in stable GFP expression system is clearly shown in our
study (Fig. 4). We have provided exquisite three-pronged
evidences of RanBP2-independent Rev-function using acute
HIV and lentiviral vector infection (Fig. 6), latent infection model
(Fig. 5) and Rev-dependent and -independent reporter systems
(Fig. 6C).
One caveat in our observations is that RanBP2 promotes
nuclear import of HIV-1 DNA. The levels of 2-LTR circles, a
marker for the nuclear import of viral genomic DNA, were
investigated and revealed that RanBP2 depletion markedly
decreased the levels of 2-LTR circles but not the viral reverse
transcription product in infected cells (Fig. 7), suggesting that
RanBP2 depletion impedes the nuclear import of viral DNA (PIC).
We further verified the post-viral DNA integration consequences
in RanBP2-depleted SVGA-LTR GFP cells infected with VSV-
HIV. Similarly, RanBP2 depletion impaired post integration
consequences such as Tat-dependent but Rev-independent GFP
expression (Fig. 6C), suggesting that the blockade occurred before
the viral DNA integration and transcription steps.
Studying the mechanism of nuclear entry of HIV-1 DNA has
attracted great attention. In earlier studies, several HIV-1 viral
components that promote nuclear import of HIV-1 PIC were
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DNA flap) and all have been found to carry karyophilic signals
[59–64]. Besides, host factors such as importin a, importin b,
importin 7, and transportin – SR2 (TNPO3) have been described
to be responsible for the nuclear import of HIV-1 DNA [44,65–
68]. In our study, we did not explore further how RanBP2
interacts with HIV-1 PIC-importin cargo complex, but it could be
interesting to pursue in the future. It would be intriguing to
identify the viral components, host importins and domains of
RanBP2 that are responsible for the interactions. Designing small
RanBP2 mimetic peptides that competitively interact with HIV-1
PIC and thus disrupt the interaction between the cargo complex
and RanBP2 would be an alternative strategy to inhibit HIV-1
replication.
In conclusion, our study provides evidence that RanBP2 is a
required host factor for HIV-1 replication and promotes the
nuclear import of viral DNA but not the nuclear export of the viral
mRNA species or nucleo-cytoplasmic trafficking of Rev (Fig. 8).
Figure 7. RanBP2 depletion inhibits 2-LTR circle formation (HIV DNA) but not viral reverse transcription. SVGA and Magi cells were
transfected either with RanBP2 siRNA, RanBP3 siRNA (negative control), scrambled siRNA or TNPO3 siRNA as a positive control. 48 h later, the cells
were transduced with 200 ng/ml p24 equivalent VSV-NL4-3 (HIV). AZT, a reverse transcriptase inhibitor, was used as a positive control to inhibit the
reverse transcription and added 30 min before VSV-HIV transduction. (A) Total DNA was extracted 24 h after VSV-HIV transduction and 2-LTR levels
were examined by real-time PCR. (B) Total DNA from SVGA cells was extracted 12 hrs after VSV-HIV transduction and the viral reverse transcription
was examined by real-time PCR.
doi:10.1371/journal.pone.0015620.g007
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Cell culture, transgenic cells, and reagent
Transgenic cell lines were established as previously described
[46]. We established SVGA-GFP, SVGA-LTR-GFP, SVGA-
LTR-gag-GFP cells for the present study [46,47]. SVGA, a human
fetal astrocytic cell line, SVGA-LTR GFP or -LTR-gag-GFP RRE
reporter cells, 293 HEK cells, and Magi (CD4/CCR5) cells [47]
were all maintained in DMEM (Gibco BRL life technologies, NY,
USA) containing 10% Fetal Bovine Serum (FBS), 100 U/ml
penicillin and 100 mg/ml streptomycin. Latently HIV infected
monocytic cell line THP89 [48] was maintained in RPMI
supplemented with 10% FBS and antibiotics. Leptomycin B and
AZT were purchased from Sigma.
Plasmids and Viral Constructs
HIV-1 proviral DNA NL4-3 from Dr. Malcolm Martin [49],
pMrev(-) from Dr. Reza Sadaie [50], and VSV-G expression plasmids
were obtained through NIH AIDS Research and Reference Reagent
Program (NIAID, Bethesda, USA). The recombinant reporter HIV-1,
NLENY1 was created by inserting the YFP gene between envelope
and Nef in NL4-3 proviral DNA [51]. HIV-1 derived lentiviral vector
pLVX was purchased from Clontech. The full length HIV-Tat and -
Rev from HXB-2b were cloned in pcDNA vector, respectively and
sequences were verified by DNA sequencing [46]. Further, Tat and a
deletion mutant of Tat (DTat) in which amino acids 48-56 were deleted
by PCR, were inserted in frame upstream of GFP gene in the pEGFP
expression vector (Clontech) [46]. The HIV long terminal repeat
(LTR)driven GFP construct wasmade by replacing CMV promoterin
the pEGFP vector with LTR promoter at SalI and SmaI [46]. pQBI-
LTR-gag-GFP was purchased from Quantum Biotechnologies Inc.
HIV/Lentiviral vector pseudotyping and infection
VSV-G pseudotyped viral particles were prepared by using
HEK 293 cells as described earlier [48]. Briefly, HEK 293 cells
were seeded in 100 mm cell culture dishes. 24 hrs later cells were
transfected with either 17 mg pNLENY1 or pNL4-3 together with
4 mg pVSV-G using Lipofectamine 2000. In order to pseudotype
lentiviral vector, cells were transfected with 10.0 mg pLVX, 3.0 mg
pCMV-Tat, 8.0 mg pGag-Pol, 4.0 mg pCMV-Rev, 2.5 mg pVpr
and 4.0 mg pVSV-G using Lipofectamine 2000. Transfection of
the plasmid expression vectors were performed as described
previously [47]. The next day, transfected cells were cultured in
fresh DMEM medium containing 10% FBS. 72 hours post
transfection; the supernatants were harvested and centrifuged at
3006g for 15 min. The pseudotyped viral stocks were titrated for
HIV p24 antigen (ZeptoMetrix, NY, USA) [52] and one ml
aliquots were stored at 280uC. Virus inoculums at 200 ng p24
concentrations were then used in transduction experiments. Magi
(CD4/CCR5) cells, SVGA cells, and SVGA-LTR-GFP reporter
cells were transduced with VSV-G pseudotyped NLENY1, or
NL4-3, or HIV-1 derived lentiviral vector. Cells were seeded in
12-well culture plates, and were transduced next day with VSV
pseudotyped NLENY1 or NL4-3 or lentiviral vector for 16 hours.
The infected cells were then washed twice and cultured in fresh
medium for another 24 hours. The GFP expression was
monitored and the images were captured by a digital camera in
a fluorescent microscope (Nikon). GFP positive cells were
measured by flow cytometry (Beckman Coulter) and the viral
activity was measured by p24 ELISA on the harvested culture
supernatants [48,52].
RNA interference
RanBP2 siRNA (sequence 59- CCGUUUUGGUGAGUCAA-
CAtt - 39, siRNA ID s11773, cat no. 4390824), positive control
GFP siRNA (cat no. AM4626) and negative control RanBP3
siRNA (sequence 59- GGAAGCCUGUGAGAAAAAAtt - 39,
siRNA ID 19354, cat no. AM16708) were purchased from
Ambion. TNPO3 siRNA (positive control) was designed by web-
based siRNA converter programs (Ambion, Austin, TX) and
sequences were synthesized by Dharmacon. TNPO3, sense 59-
CGACAUUGCAGCUCGUGUAUU-39, and antisense 59-UA-
CACGAGCUGCAAUGUCGUU-39; Scrambled siRNA from
Dharmacon was used as a control. For siRNA transfection,
Lipofectamine 2000 (Invitrogen) was used according to the
manufacturer’s guidelines.
siRNA transfection and reactivation of latent HIV
THP89 cells, a latently HIV-1 infected monocytic cell line
[47,48], were seeded into 12-well culture plates. 48 hrs later, cells
were transfected with RanBP2 siRNA, RanBP3 siRNA (negative
control), TNPO3 siRNA (positive control), scramble siRNA
(control), or GFP siRNA (positive control). The basal viral activity
in THP89 cells was barely detectable with complete absence of
GFP-expression and p24 [48,52]. Viral reactivation was per-
formed 48 hours post siRNA transfection with 25 ng/ml bryos-
tatin (Enzo life sciences). Images were captured followed by
collection of the culture supernatants for p24 analysis and GFP
positive cells were measured by Flow Cytometry after 48 hrs of
bryostatin treatment [52].
Flow cytometry
The percentages of GFP positive cells were measured in a Epics
XL FACS flowcytometer with Expo32 software (Beckman
Coulter, Inc., FL, USA). The cells were trypsinized, followed by
Figure 8. Schematic diagram illustrating role of RanBP2 in HIV-
1 DNA (PIC) nuclear import. HIV-1 entry follows partial uncoating of
HIV particles with concomitant viral RNA reverse transcription into
cDNA and assembly into PIC with viral proteins MA, Vpr and integrase.
The PIC import into the nucleus is facilitated by nuclear membrane
component RanBP2. RanBP2 depletion via RNAi inhibits PIC import into
the nucleus. The PIC import is detected by the 2-LTR circles (marker of
HIV DNA nuclear import). RanBP2 is not involved in HIV-Rev protein
nuclear import/export as demonstrated by HIV replication (GFP
expression as a marker or viral p24 antigen) seen in HIV latent THP89
model (HIV reactivation by bryostatin).
doi:10.1371/journal.pone.0015620.g008
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1% FBS. In a situation of reactivated THP89 cells or cells that
were transduced with VSV-NLENY1 or VSV-NL4-3 viruses, 3%
paraformaldehyde was used to fix the cells for 30 min at 4uC
followed by washing with PBS.
Western Blotting
Magi, SVGA, or THP89 cells were transfected either with
RanBP2- or RanBP3-siRNA and were harvested 72 hrs post
transfection. The cells were lysed in RIPA buffer (Sigma) and total
proteins in equal amounts were subjected to SDS-PAGE. Proteins
were then transferred to polyvinylidene difluoride (PVDF)
membranes (pore size 0.2 mm, BioRad). For RanBP2 detection,
5% SDS-PAGE gel was used to separate the total cellular proteins
and followed by transfer to PVDF membrane at 30 V for
24 hours, using transfer buffer containing 10% methanol with
0.5% SDS. The membranes were blocked for 1 hr at room
temperature with blocking buffer (5% nonfat dry milk, 0.1%
Tween 20 in PBS). The blotted membranes were probed overnight
at 4uC with rabbit polyclonal antibody against RanBP2 (1:500
dilutions, abcam) in blocking buffer. After three washes with PBS/
0.1% Tween 20, the membranes were incubated with anti-rabbit
IgG conjugated to horseradish peroxidase secondary antibody
(1:10’000 dilution, sigma) in blocking buffer for 1 hr at room
temperature. The membranes were washed three times with PBS/
0.1% Tween 20 and developed using chemiluminescence (ECL)
detection kit (GE Healthcare). As an internal control, actin was
probed with mouse monoclonal antibody against actin (1:5000
dilution, Sigma) and then with anti-mouse IgG (1:10’000 dilution,
Sigma). To detect the level of RanBP3, we used rabbit polyclonal
antibody against RanBP3 (1:1000 dilution, abcam). The protein
bands were normalized to b-actin (1:10000) and were quantified
using ImageJ software (v 1.41; NIH) [52].
DNA extraction and Real time PCR
In each case, the cells were trypsinized and washed twice with
PBS and centrifuged at 3006g for 15 min. One ml DNAzol
(Invitrogen) was added to cell pellet and 0.5 ml 100% ethanol
(Sigma) was used to precipitate DNA. The precipitated DNA was
then washed with 75% ethanol twice and dissolved in 8 mM
NaOH (pH 8.0) [47]. PCR amplification was performed in a 25 ml
reaction mix containing 25 pmol of each primer, 2 X SYBR mix
(BioRad) and 1 ml DNA template. The cycle program used was
95uC/10 min followed by 95uC/10 s, 60uC/30 s, and 72uC/30 s
for 39 cycles. Reactions were run on CFX96 real time PCR system
(Bio-RAD) and data was collected and analyzed using Bio-RAD
CFX Manager Software v 1.1. Ct values were calculated for each
gene and normalized relative to GAPDH expression. Fold
expression from untreated control or DDCt was calculated using
Paffafl method.
The following primers were used:
2-LTR forward: 59-CCCTCAGACCCTTTTAGTCAGTG-39,
2-LTR reverse: 59-TGGTGTGTAGTTCTGCCAATCA-39;
GAPDH forward: 59- GTCAAGGCTGAGAACGGGAAGC-39,
GAPDH reverse: 59- AGGGATCTCGCTCCTGGAAGAT-
GG-39
To quantify viral reverse transcription products, we used Tat
primers:
Tat forward: 59- GAAGCATCCAGGAAGTCAGCC-39,
Tat reverse: 59- ACAAACTTGGCAATGAAAGCAACAC-39
Statistical analysis
Results are represented as mean 6 SE for each bar graph. The
significance between two groups was calculated using student’s t-
test. p,0.05 was considered significant.
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